This finding aligns with previous reports linking elevated serum PTX3 levels to type 2 diabetes in obese patients with nonalcoholic fatty liver disease, indicating the clinical relevance of PTX3 in metabolic disorders (Karamfilova et al., 2022, Trojak et al., 2019). This evidence concerns the gene PTX3 and type 2 diabetes mellitus.